* Mesa Laboratories Inc MLAB.OQ MLAB.O is expected
to show a
rise in quarterly revenue when it reports results on February 5
for the period ending December 31 2023
* The Lakewood Colorado-based company is expected to report
a
1.1% increase in revenue to $54.893 million from $54.29 million
a year ago, according to the mean estimate from 2 analysts,
based on LSEG data.
* LSEG's mean analyst estimate for Mesa Laboratories Inc is
for
earnings of 19 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Mesa
Laboratories
Inc is $115.00, above its last closing price of $94.07.
This summary was machine generated February 2 at 15:03 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)